BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 29127715)

  • 1. Relationship between preoperative breast MRI and surgical treatment of non-metastatic breast cancer.
    Onega T; Weiss JE; Goodrich ME; Zhu W; DeMartini WB; Kerlikowske K; Ozanne E; Tosteson ANA; Henderson LM; Buist DSM; Wernli KJ; Herschorn SD; Hotaling E; O'Donoghue C; Hubbard R
    J Surg Oncol; 2017 Dec; 116(8):1008-1015. PubMed ID: 29127715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growing Use of Contralateral Prophylactic Mastectomy Despite no Improvement in Long-term Survival for Invasive Breast Cancer.
    Wong SM; Freedman RA; Sagara Y; Aydogan F; Barry WT; Golshan M
    Ann Surg; 2017 Mar; 265(3):581-589. PubMed ID: 28169929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Preoperative Magnetic Resonance Imaging in the Assessment and Surgical Treatment of Interval and Screen-Detected Breast Cancer in Older Women.
    Goodrich ME; Weiss J; Onega T; Balch SL; Buist DS; Kerlikowske K; Henderson LM; Hubbard RA;
    Breast J; 2016 Nov; 22(6):616-622. PubMed ID: 27550072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benefits of preoperative MRI in breast cancer surgery studied in a large population-based cancer registry.
    Vos EL; Voogd AC; Verhoef C; Siesling S; Obdeijn IM; Koppert LB
    Br J Surg; 2015 Dec; 102(13):1649-57. PubMed ID: 26445887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of breast reconstruction on the decision to undergo contralateral prophylactic mastectomy.
    Ashfaq A; McGhan LJ; Pockaj BA; Gray RJ; Bagaria SP; McLaughlin SA; Casey WJ; Rebecca AM; Kreymerman P; Wasif N
    Ann Surg Oncol; 2014 Sep; 21(9):2934-40. PubMed ID: 24756811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends and clinical implications of preoperative breast MRI in Medicare beneficiaries with breast cancer.
    Killelea BK; Long JB; Chagpar AB; Ma X; Soulos PR; Ross JS; Gross CP
    Breast Cancer Res Treat; 2013 Aug; 141(1):155-63. PubMed ID: 23942872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contralateral prophylactic mastectomy in an Asian population: a single institution review.
    Sim Y; Tan VK; Ho GH; Wong CY; Madhukumar P; Tan BK; Yong WS; Ng YY; Ong KW
    Breast; 2014 Feb; 23(1):56-62. PubMed ID: 24275318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bilateral Mastectomy versus Breast-Conserving Surgery for Early-Stage Breast Cancer: The Role of Breast Reconstruction.
    Albornoz CR; Matros E; Lee CN; Hudis CA; Pusic AL; Elkin E; Bach PB; Cordeiro PG; Morrow M
    Plast Reconstr Surg; 2015 Jun; 135(6):1518-1526. PubMed ID: 26017588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of breast MRI in high-risk patients with newly diagnosed breast cancer to exclude invasive disease in the contralateral prophylactic mastectomy: Is there a role to choose wisely patients for sentinel node biopsy?
    Freitas V; Crystal P; Kulkarni SR; Ghai S; Bukhanov K; Escallon J; Scaranelo AM
    Cancer Med; 2016 Jun; 5(6):1031-6. PubMed ID: 26992816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rate of contralateral prophylactic mastectomy is influenced by preoperative MRI recommendations.
    Xia C; Schroeder MC; Weigel RJ; Sugg SL; Thomas A
    Ann Surg Oncol; 2014 Dec; 21(13):4133-8. PubMed ID: 24934585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growing Trends of Contralateral Prophylactic Mastectomy and Reconstruction in Young Breast Cancer.
    Chen H; Zhang P; Zhang M; Wang M; Bai F; Wu K
    J Surg Res; 2019 Jul; 239():224-232. PubMed ID: 30856515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical management factors contribute to the decision for contralateral prophylactic mastectomy.
    King TA; Sakr R; Patil S; Gurevich I; Stempel M; Sampson M; Morrow M
    J Clin Oncol; 2011 Jun; 29(16):2158-64. PubMed ID: 21464413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Locoregional treatment of breast cancer in women with and without preoperative magnetic resonance imaging.
    Ozanne EM; Weiss JE; Onega T; DeMartini W; Kerlikowske K; Buist DS; Henderson L; Hubbard RA; Goodrich M; Tosteson AN; Virnig BA; O'Donoghue C
    Am J Surg; 2017 Jan; 213(1):132-139.e2. PubMed ID: 27421187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A standard mastectomy should not be the only recommended breast surgical treatment for non-metastatic inflammatory breast cancer: A large population-based study in the Surveillance, Epidemiology, and End Results database 18.
    Chen H; Wu K; Wang M; Wang F; Zhang M; Zhang P
    Breast; 2017 Oct; 35():48-54. PubMed ID: 28649032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Higher Stage of Disease Is Associated With Bilateral Mastectomy Among Patients With Breast Cancer: A Population-Based Survey.
    Freedman RA; Kouri EM; West DW; Rosenberg S; Partridge AH; Lii J; Keating NL
    Clin Breast Cancer; 2016 Apr; 16(2):105-12. PubMed ID: 26410475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contralateral Prophylactic Mastectomy: Factors Predictive of Occult Malignancy or High-Risk Lesion and the Impact of MRI and Genetic Testing.
    Erdahl LM; Boughey JC; Hoskin TL; Degnim AC; Hieken TJ
    Ann Surg Oncol; 2016 Jan; 23(1):72-7. PubMed ID: 26065870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors Associated with Preoperative Magnetic Resonance Imaging Use among Medicare Beneficiaries with Nonmetastatic Breast Cancer.
    Henderson LM; Weiss J; Hubbard RA; O'Donoghue C; DeMartini WB; Buist DS; Kerlikowske K; Goodrich M; Virnig B; Tosteson AN; Lehman CD; Onega T
    Breast J; 2016; 22(1):24-34. PubMed ID: 26511204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increasing use of elective mastectomy and contralateral prophylactic surgery among breast conservation candidates: a 14-year report from a comprehensive cancer center.
    Dragun AE; Pan J; Riley EC; Kruse B; Wilson MR; Rai S; Jain D
    Am J Clin Oncol; 2013 Aug; 36(4):375-80. PubMed ID: 22643566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mastectomy patterns, but not rates, are changing in the treatment of early breast cancer. Experience of a single European institution on 2315 consecutive patients.
    Fancellu A; Sanna V; Cottu P; Feo CF; Scanu AM; Farina G; Bulla A; Spanu A; Paliogiannis P; Porcu A
    Breast; 2018 Jun; 39():1-7. PubMed ID: 29454174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic breast magnetic resonance imaging and contralateral prophylactic mastectomy.
    Sorbero ME; Dick AW; Beckjord EB; Ahrendt G
    Ann Surg Oncol; 2009 Jun; 16(6):1597-605. PubMed ID: 19330381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.